Advertisement

Transfection of Difficult-to-Transfect Primary Mammalian Cells

  • Oliver Gresch
  • Ludger Altrogge
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 801)

Abstract

Primary cells are a valuable tool for researchers and are often preferred over transformed or immortalized cell lines since they are biologically more relevant and resemble the in vivo situation much closer. Unfortunately, efficient gene transfer in primary cells is still limited. Whereas viral strategies are time consuming and involve safety risks, nonviral methods are often inefficient for most primary cells. Nucleofection has been proven to overcome these limitations. Here, we describe the Nucleofection protocol for efficient transfection of human umbilical vein endothelial cells. Using a combination of a cell type-specific solution and electrical conditions, transfection efficiencies up to 90% can be achieved while survival rate is more than 70%.

Key words

Transfection Primary cells Nucleofection HUVEC Luciferase 

References

  1. 1.
    Haleem-Smith, H., Derfoul, A., Okafor, C., et al. (2005) Optimization of high-efficiency transfection of adult human mesenchymal stem cells in vitro. Mol. Biotechnology 30, 9–20.Google Scholar
  2. 2.
    Kimmelman, J. (2005) Recent developments in gene transfer: risk and ethics. BMJ 330, 79–82.Google Scholar
  3. 3.
    Williams, D., and Baum, C. (2003) Gene Therapy – New Challenges Ahead. Science 302, 400.Google Scholar
  4. 4.
    Thomas, C. E., Ehrhardt, A., and Kay, M. A. (2003) Progress and problems with the use of viral vectors for gene therapy. Nat. Rev. Genet. 4(5), 346–58.Google Scholar
  5. 5.
    Lakshmipathy, U., Buckley, S., and Verfaillie, C. (2007) Gene transfer via nucleofection into adult and embryonic stem cells. Methods Mol. Biol. 407, 115–26.Google Scholar
  6. 6.
    Zeitelhofer, M., Vessey, J.P., Xie, Y., et al. (2007) High-efficiency transfection of mammalian neurons via nucleofection. Nat. Protoc. 2(7),1692–704.Google Scholar
  7. 7.
    Landi, A., Babiuk, L.A., and van Drunen Littel-van den Hurk S. (2007) High transfection efficiency, gene expression, and viability of monocyte-derived human dendritic cells after nonviral gene transfer. J Leukoc Biol. 82(4), 849–60.Google Scholar
  8. 8.
    Gerber, S.A., and Pober, J.S. (2008) IFN-alpha induces transcription of hypoxia-inducible factor-1alpha to inhibit proliferation of human endothelial cells. J. Immunol. 181(2), 1052–62.Google Scholar
  9. 9.
    Kapoor, M., Zhou, Q., Otero, F., et al. (2008) Evidence for annexin II/S100A10 complex and plasmin in mobilization of cytokine activity of human TrpRS. J. Biol. Chem. 283(4), 2070–2077.Google Scholar
  10. 10.
    Gresch, O., Engel, F.B., Nesic, D., et al. (2004) New non-viral method for gene transfer into primary cells. Methods 33, 151–163.Google Scholar
  11. 11.
    Browne, C.D., Hindmarsh, E.J., and Smith, J.W. (2006) Inhibition of endothelial cell ­proliferation and angiogenesis by orlistat, a fatty acid synthase inhibitor. FASEB J. 20(12), 2027–35.Google Scholar
  12. 12.
    Benny, O., Fainaru, O., Adini, A., et al. (2008) An orally delivered small-molecule formulation with antiangiogenic and anti­cancer activity. Nat Biotechnol. 26(7), 799–807.Google Scholar
  13. 13.
    Chen, Y., Wei, T., Yan, L. (2008) Developing and applying a gene functional association ­network for anti-angiogenic kinase inhibitor activity assessment in an angiogenesis co-culture model. BMC Genomics. 9, 264–279.Google Scholar
  14. 14.
    Fan, F., and Wood, K.V. (2007) Bioluminescent assays for high-throughput screening. Assay Drug Dev. Technol. 5, 127–136.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Lonza Cologne GmbHCologneGermany

Personalised recommendations